March 3, 2026

Select Medical Holdings Corp (SEM) Stock Analysis: Discover the 14.27% Potential Upside in Healthcare

Select Medical Holdings Corporation (NYSE: SEM) stands as a formidable entity within the healthcare sector, particularly in the medical care facilities industry. With a market capitalization..

Addus HomeCare Corporation (ADUS) Stock Analysis: Potential 33% Upside for Savvy Investors

Addus HomeCare Corporation (NASDAQ: ADUS) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of..

Enovis Corporation (ENOV): Investor Outlook on a Promising 75.8% Potential Upside

Investors seeking opportunities in the healthcare sector may find Enovis Corporation (ENOV) an intriguing choice, especially with a potential upside of 75.8% as indicated by the..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Promising Biotech with 35.82% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical leader in rare and orphan diseases, is making waves in the biotechnology sector with its innovative therapies and robust..

Bausch Health Companies Inc. (BHC) Stock Analysis: Unveiling a Potential 29.65% Upside

Bausch Health Companies Inc. (NYSE: BHC), a diversified specialty pharmaceutical and medical device company headquartered in Laval, Canada, is a name that has long been associated..

Metsera, Inc. (MTSR) Stock Analysis: Biotechnology Innovator Faces Potential Downside Despite Strong Buy Ratings

Metsera, Inc. (MTSR), a clinical-stage biotechnology company based in New York, is making waves in the healthcare sector with its promising pipeline of hormone analog peptides..

CRISPR Therapeutics AG (CRSP) Investor Outlook: Biotechnology Innovator Poised for a 39.51% Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) stands as a compelling player in the biotechnology sector, with its innovative focus on gene editing technologies. This Swiss company has..

Arrowhead Pharmaceuticals, Inc. (ARWR)

⚠️ No article content returned.

..

Tarsus Pharmaceuticals (TARS) Stock Analysis: Strong Buy Ratings and 21.88% Upside Potential

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) stands at the forefront of the biopharmaceutical industry with a primary focus on eye care therapeutics. The company’s strategic developments and..

HUTCHMED (China) Limited (HCM) Stock Analysis: Potential Upside of 51.89% Amid Unique Growth Opportunities

HUTCHMED (China) Limited (HCM), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents an intriguing investment opportunity with..

Warby Parker Inc. (WRBY) Investor Outlook: Eyeing a 9.04% Upside with Strong Buy Ratings

Warby Parker Inc. (NYSE: WRBY) is shaping up as an intriguing opportunity for investors in the healthcare sector, specifically within the Medical Instruments & Supplies industry...

Denali Therapeutics Inc. (DNLI) Investor Outlook: Analyzing the 56.80% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company at the forefront of developing treatments for neurodegenerative and lysosomal storage diseases, is capturing investor attention with a..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Navigating the Biotech Sector with a 23.7% Revenue Growth

Amicus Therapeutics, Inc. (NASDAQ: FOLD) has been making waves in the biotechnology industry, a sector known for its potential to deliver transformative healthcare solutions and significant..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 56.76% Potential Upside in Biotech

Vericel Corporation (NASDAQ: VCEL), a dynamic player in the biotechnology sector, offers a captivating prospect for investors with its focus on innovative cellular therapies and specialty..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating a Challenging Landscape with Insights into Valuation and Dividend Potential

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a key player in the medical instruments and supplies industry, commands attention with its robust market presence in the healthcare sector...

Certara, Inc. (CERT) Stock Analysis: Exploring a 38% Potential Upside in Health Information Services

Certara, Inc. (NASDAQ: CERT), a notable player in the healthcare sector, offers a compelling narrative with its technology-driven services and software products designed for biosimulation. As..

Apogee Therapeutics (APGE) Stock Analysis: Exploring a 47.76% Potential Upside in the Biotech Sector

Apogee Therapeutics, Inc. (NASDAQ: APGE) is a promising name in the biotechnology industry, boasting a market capitalization of $4.84 billion. Operating within the healthcare sector, Apogee..

LivaNova PLC (LIVN) Stock Analysis: A Promising Upside of 13.72% Amid Robust Revenue Growth

LivaNova PLC (NASDAQ: LIVN), a key player in the healthcare sector’s medical devices industry, is capturing investor attention with its robust revenue growth and significant potential..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Exploring a 146.81% Potential Upside in the Biotech Sector

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is making waves in the biotech sector, marked by a robust market capitalization of $2.16 billion and a promising pipeline of..

Apellis Pharmaceuticals (APLS) Stock Analysis: Exploring a 62.73% Upside Potential in Biotech

For investors with a keen interest in the biotechnology sector, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents an intriguing opportunity. The company, headquartered in Waltham, Massachusetts, focuses..

Search

Funds

March 3, 2026

Search

Funds

March 3, 2026

FTSE 100

Funds